Trade Summary

2 days ago, Hoge Stephen, serving as President at Moderna, Inc. (MRNA), sold 53,336 shares at $67.60 per share, for a total transaction value of $3,605,513.60. Following this transaction, Hoge Stephen now holds 1,483,848 shares of MRNA.

This sale represents a 3.47% decrease in Hoge Stephen's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 4:45 PM ET, 1 day after the trade was made.

Moderna, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.